Hypertrophic Cardiomyopathy (HCM)
Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart condition in the US, and is thought affect nearly 20 million individuals world wide. It is a condition where the muscle of the heart becomes thickened, or hypertrophied. In some cases, the thickened muscle can make it difficult for blood to flow out of the heart. We call this Hypertrophic Obstructive Cardiomyopathy (HOCM). Symptoms may include shortness of breath especially with exertion, palpitations, chest pain, or fainting.
Individuals with HCM or HOCM are at higher risk of events such as stroke, abnormal heart rhythms, heart failure, and sudden cardiac death. At CVISD, we work with our patients to thoroughly evaluate risk for these events and create a treatment plan that works best for each individual patient. Treatments may include medications, implantable cardiac defibrillators, and in some cases surgical procedures. Cardiovascular Institute is proud to be the first center in the south bay to offer mavacamten, a novel medicine to help reduce the severity of symptoms in patients with HOCM.
Please contact our office to schedule an appointment with our HCM and HOCM specialists.